Section 338.3122. Schedule 3; anabolic steroids; exemptions.  


Latest version.

All data is extracted from pdf, click here to view the pdf.

  • (1) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of an anabolic steroid, including its salts, isomers, and salts of isomers if the existence of such salts of isomers is possible within the specific chemical designation, is included in schedule 3. As used in this rule, the term "anabolic steroid means any of the following drugs  or hormonal substances which are chemically and pharmacologically related to testosterone, other than estrogens, progestins, and corticosteroids, and which promote muscle growth:

    Substance

    a

    1-Androstenediol  (3beta,17beta-dihydroxy-5alpha-androst-1-ene;  3alpha,17beta- dihydroxy-5alphaandrost-1-ene)

    b

    1-Androstenedione    (5alpha-androst-1-en-3,17-dione)

    c

    3Alpha,17beta-dihydroxy-5alpha-androstane

    d

    3Beta,17beta-dihydroxy-5alpha-androstane

    e

    4-Androstenediol     (3beta,17beta-dihydroxy-androst-4-ene)

    f

    4-Androstenedione    (androst-4-en-3,17-dione)

    g

    4-Hydroxy-19-nortestosterone     (4,17beta-dihydroxyestr-4-en-3-one)

    h

    4-Hydroxytestosterone     (4,17beta-dihydroxyandrost-4-en-3-one)

    i

    5-Androstenediol     (3beta,17beta-dihydroxy-androst-5-ene)

    j

    5-Androstenedione    (androst-5-en-3,17-dione)

    k

    13Beta-ethyl-17beta-hydroxygon-4-en-3-one

    l

    17Alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane

    m

    17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane

    n

    17Alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene

    o

    17Alpha-methyl-4-hydroxynandrolone                        (17alpha-methyl-hydroxy-17beta- hydroxyestr-4-en-3-one)

    p

    17Alpha-methyl-delta1-dihydrotestosterone                 (17beta-hydroxy-17alpha-methyl- 5alpha-androst-1-en-3-one)

    q

    19-nor-4, 9(10)-androstadienedione.

    r

    19-nor-5-androstendedione (estr-5-en-3, 17-dione)

    s

    Boldenone

    t

    Bolasterone

    u

    Boldione

    v

    Calusterone

    w

    4-chlortestosterone (clostebol)

    x

    Dehydrochlormethyltestosterone

    y

    Desoxymethyltestosterone

    z

    Drostanolone

    aa

    Ethylestrenol

    bb

    Fluoxymesterone

    cc

    Formebolone

    dd

    Mesterolone

    ee

    Methandriol

    ff

    Methandrostenolone (methandienone)

    gg

    Methasterone

    hh

    Methenolone

    ii

    Methyltestosterone

    jj

    Mibolerone

    kk

    Nandrolone

    ll

    Norethandrolone

    mm

    Oxandrolone

    nn

    Oxymesterone

    oo

    Oxymetholone

    pp

    Prostanozol

    qq

    Stanolone (4-dihydrotestosterone)

    rr

    Stanozolol

    ss

    Testolactone

    tt

    Testosterone

    uu

    Trenbolone

    vv

    Any salt, ester, or isomer of a drug or substance described or listed in this subrule, if that salt, ester, or isomer promotes muscle growth.

    (2)               An anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States drug enforcement administration for such administration is specifically excepted from schedule 3.

    (3)         The following  anabolic steroid  products are exempted from all schedules  of controlled substances:

    Substance

    a

    Esterified estrogens 1.25 milligrams and methyl testosterone 2.5 milligram tablets.

    b

    Esterified  estrogens  0.625  milligrams  and  methyl  testosterone   1.25  milligram tablets.

    c

    Conjugated  estrogens   1.25  milligrams   and  methyl   testosterone  10   milligram tablets.

    d

    Conjugated  estrogens  0.625  milligrams  and  methyl  testosterone  5  milligram tablets.

    e

    Testosterone       enanthate      90    milligram/milliliter        and     estradiol      valerate      4 milligram/milliliter injection.

History: 1992 AACS; 1994 AACS; 2013 AACS.